Cargando…

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

Molecular markers involved in DNA repair can help to predict survival in gastric cancer patients treated with 5-FU plus platinum chemotherapy. Excision repair cross-complementing 1 (ERCC1) and thymidylate synthase (TS) mRNA expression levels were assessed in advanced gastric cancer tumour samples us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, J, Zou, Z, Qian, X, Ding, Y, Xie, L, Sanchez, J J, Zhao, Y, Feng, J, Ling, Y, Liu, Y, Yu, L, Rosell, R, Liu, B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361707/ https://www.ncbi.nlm.nih.gov/pubmed/18362936 http://dx.doi.org/10.1038/sj.bjc.6604317

Ejemplares similares

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
por: Park, S R, et al.
Publicado: (2011)

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
por: Matsubara, J, et al.
Publicado: (2008)

Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis
por: Tsuji, S, et al.
Publicado: (2012)

High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment
por: Ma, G-F, et al.
Publicado: (2014)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
por: Kawamoto, Y, et al.
Publicado: (2012)

A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions
por: Xu, Z-q, et al.
Publicado: (2013)

DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
por: O'Connor, J P B, et al.
Publicado: (2011)

MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
por: Zhang, P, et al.
Publicado: (2017)

Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration
por: Dong, Z, et al.
Publicado: (2014)

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer
por: Kim, J C, et al.
Publicado: (2013)

Nucleostemin mRNA is expressed in both normal and malignant renal tissues
por: Fan, Y, et al.
Publicado: (2006)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases
por: Kita, Y, et al.
Publicado: (2009)

Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer
por: He, H, et al.
Publicado: (2014)

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
por: Basso, M, et al.
Publicado: (2013)

The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome
por: Robinson, S M, et al.
Publicado: (2013)

Notch1 activation is a poor prognostic factor in patients with gastric cancer
por: Zhang, H, et al.
Publicado: (2014)

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer
por: Zhu, C, et al.
Publicado: (2014)

Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer
por: Wei, J, et al.
Publicado: (2014)

Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
por: Liang, J, et al.
Publicado: (2013)

CTL- vs T(reg) lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma
por: Liu, J Y, et al.
Publicado: (2015)

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer
por: Chen, L, et al.
Publicado: (2014)

Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
por: Li, J, et al.
Publicado: (2009)

Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
por: Meng, X N, et al.
Publicado: (2009)

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
por: Nam, S Y, et al.
Publicado: (2011)

LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
por: Ding, J, et al.
Publicado: (2013)

Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer
por: Xi, H Q, et al.
Publicado: (2014)

FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer
por: Yang, S S, et al.
Publicado: (2017)

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
por: Qiao, G-B, et al.
Publicado: (2005)

Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients’ survival
por: Ren, J, et al.
Publicado: (2011)

Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells
por: Fuyuhiro, Y, et al.
Publicado: (2011)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer
por: Okugawa, Y, et al.
Publicado: (2013)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

REG Iα is a biomarker for predicting response to chemotherapy with S-1 plus cisplatin in patients with unresectable stage IV gastric cancer
por: Sekikawa, A, et al.
Publicado: (2013)

A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma
por: Sun, Y-W, et al.
Publicado: (2014)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
por: An, H, et al.
Publicado: (2014)

Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex
por: Ji, Q, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3hs5o56rj6l94duher5ra5jhhk